Can An Mri Diagnose Alzheimers
The simplest answer to the question is yes. The more complicated answer considers that there is still a lot of research to do on this disease, so it may be a while before we establish a definitive test to diagnose Alzheimers disease.
However, for the time being, using an MRI to detect Alzheimers is one of the best options available.
Why Early Detection Can Be Difficult
Alzheimers disease usually is not diagnosed in the early stages, even in people who visit their primary care doctors with memory complaints.
- People and their families generally underreport the symptoms.
- They may confuse them with normal signs of aging.
- The symptoms may emerge so gradually that the person affected doesnt recognize them.
- The person may be aware of some symptoms but go to great lengths to conceal them.
Recognizing symptoms early is crucial because medication to control symptoms is most effective in the early stages of the disease and early diagnosis allows the individual and his or her family members to plan for the future. If you or a loved one is experiencing any of the following symptoms, contact a physician.
Measure Volume In The Brain
An MRI can provide the ability to view the brain with 3D imaging. It can measure the size and amount of cells in the hippocampus, an area of the brain that typically shows atrophy during the course of Alzheimer’s disease. The hippocampus is responsible for accessing memory which is often one of the first functions to noticeably decline in Alzheimer’s.;
An MRI of someone with Alzheimer’s disease may also show parietal atrophy. The parietal lobe of the brain is located in the upper back portion of the brain and is responsible for several different functions including visual perception, ordering and calculation, and the sense of our body’s location.
Symptom History Of Alzheimers Disease
One of the questions the doctor will ask is if the person is experiencing any symptoms of Alzheimers disease. The doctor will be looking for symptoms that are more severe than the normal signs of aging, depending on the persons age and education.2 Symptoms can include things like memory impairment, trouble problem-solving or planning, getting lost or confused easily, losing time or becoming confused about the passing of time, visual-spatial difficulties, language problems, poor judgment or decision-making, social withdrawal, and mood changes.3 Not only will the doctor see what symptoms are present, but also the frequency and severity of the symptoms. If symptoms have gotten progressively worse, thats important for the doctor to know. Having one or more of these symptoms does not necessarily mean a person has Alzheimers, but it can give the doctor clues and insight as to what might be going on, and what other tests to run.
The Current Status Of Alzheimers Pet Imaging
- May 12, 2020
Alzheimers disease is the sixth leading cause of death in the United States. Around one in three American seniors die from Alzheimers or another dementia, making it a bigger killer than breast and prostate cancer combined.
In fact, deaths from Alzheimers disease increased 145% between 2000 and 2017 and it is estimated that 10% of people over 65 have the disease.
While the underlying disease cannot be stopped at this time, early diagnosis is very beneficial to patients and their families. Receiving treatment early can help to preserve daily functioning for a longer period and allows the patient and their family time to plan for the future. Its preferable that things like legal and living arrangements are made while the patient is able to make decisions for themselves.
This is where it gets complicated Alzheimers disease is notoriously difficult to diagnose. One reason for this is that patients often under-report their symptoms. Doctors might make a diagnosis of probable or possible Alzheimers dementia, but they can usually only go by what patients and their families are reporting, along with testing to rule out other possible causes of symptoms.
The amyloid plaques are a hallmark of Alzheimers disease and detecting them can help to provide an early diagnosis and subsequent action plan for the living patient.
Read Also: How Do You Know If You Have Dementia
Whats Next After The Amyloid Pet Scan
In the treatment of Alzheimers disease, the positive indicator for amyloid plaque on the brain is just the beginning for the patient. What happens next?
If amyloid plaque is detected, then physicians can make a more informed diagnosis of Alzheimers disease. With this in-hand, the patient, their physician and their family can devise a plan to prolong their functioning abilities and to prepare for such a time as when theyre no longer able to manage daily life without help.
Another possible outcome is access to drug trials for Alzheimers disease. There are many such trials which require a positive Amyloid PET scan in order to gain access. Given the difficulty with definitively diagnosing Alzheimers, scientists want to be sure that the people participating in their trials truly do have the disease.
This has been an issue that PET scans have helped with. It has been found that many people being treated for Alzheimers disease dont in fact have it. While the presence of amyloid plaque doesnt always indicate Alzheimers disease, no presence of amyloid plaque means the patient does not have the disease.
A PET scan resulting in no Alzheimers diagnosis can significantly change the care plan of the patient. Physicians can then look for other underlying causes of the patients symptoms. For example, sometimes they may be related to sleep disturbances, vitamin deficiencies, mood disorders, mercury toxicity or other causes of cognitive impairment.
Get the bonus content:
What Are The Benefits Of An Early Alzheimer’s Diagnosis
Early, accurate diagnosis is beneficial for several reasons. Beginning treatment early in the disease process may help preserve daily functioning for some time, even though the underlying Alzheimers process cannot be stopped or reversed.
Having an early diagnosis helps people with Alzheimers and their families:
Don’t Miss: How Do You Treat Someone With Dementia
Alzheimer’s Disease Q & A
What is Alzheimers disease?
Alzheimers disease is a progressive and irreversible disease that attacks the brain cells and impairs a persons cognitive functions, including their ability to remember and their ability to perform physical and mental tasks. Alzheimers occurs in stages, with impairment becoming progressively worse over time. Sometimes, the disease progresses quickly, but often, it takes years for the patient to progress from one stage to another. The disease begins with structural changes in the brain that can occur years before any noticeable symptoms develop. In this preclinical stage, proteins build up in the brain and tangled clumps of fibers form, interfering not only with nerve transmissions associated with physical and mental processes but also preventing the normal flow of oxygen- and nutrient-rich blood, starving brain cells and causing the brain to atrophy over time.
How is Alzheimers disease diagnosed?
Although Alzheimers disease is the most common cause of dementia in the U.S., its not the only cause. While there are no tests to definitively diagnose Alzheimers disease , it can be diagnosed differentially – that is, by ruling out other possible causes of symptoms. Dr. McKenzie will use several techniques to diagnose Alzheimers disease, including:
How is Alzheimers disease treated?
Ruling Out Other Conditions
Because symptoms of Alzheimers disease, especially in the early stages, are similar to other neurological diseases or other ailments, its important to rule out any other possible explanation for the symptoms. Possible differential diagnoses can include other forms of neurocognitive disorders, medication interactions, adverse drug effects, stroke, brain tumor, or hemorrhage.3 The treatments for each underlying cause vary widely, and so its imperative to get an accurate diagnosis.
Read Also: What Diseases Are Similar To Alzheimer’s
The Difficulty Of Detecting Alzheimers Disease
Alzheimers disease is a progressive neurodegenerative disease. It is the leading cause of dementia. Alzheimers disease eventually leads to death and no cure currently exists, although medication and supportive treatments can temporarily relieve symptoms.
Alzheimers is hard to definitively diagnose at an early stage. Because symptoms are often subtle and gradual at first, the ongoing, irreversible damage is not easy to detect until it is more advanced. Alzheimers can definitively be diagnosed only by analyzing brain tissue after death.
While detecting Alzheimers disease in a living patient is difficult, imaging technology has made strides toward this goal in recent years. Positron emission tomography and magnetic resonance imaging allow for high resolution images of brain features. These scans can show structural changes related to Alzheimers, such as twisted fibers within brain cells and amyloid plaques . They can also detect dynamic features such as how brain cells use glucose.
However, imaging scans such as PET and MRI are expensive, technically demanding, and contribute little to early detection.
New Possibilities For Tracking Disease Progression And Treatment
Beyond helping to identify Alzheimers disease, the new technology could also lead to improved treatments, say the researchers. Large clinical trials are still needed to determine whether spectroscopy readings can track disease progression. If they can, explain the researchers, this approach could become a safe, non-invasive method for assessing response to treatments in real time.
The new technology could be especially helpful for Veterans. As lead author Dr. Frank Greco explains, Veterans are more at risk for Alzheimers disease than the general population. This technique has the potential to help identify what factors may increase that risk.
The spectroscopy method has been accepted by the Food and Drug Administration as a protocol for possible clinical use. Before it can be put into practice, clinical trials will need to be conducted. The researchers are working on refining the design of the probe and the specifications of the spectrometer, software, and interpretation of the output toward that end.
Read Also: Does Diet Coke Cause Alzheimer’s
Pathology Of Alzheimers Disease
Gross Anatomy of Alzheimers Brain. Lateral view of an Alzheimers brain can show widening of sulcal spaces and narrowing of gyri compared to a normal brain. This may be more readily observed in coronal sections as indicated by the arrowheads, and this atrophy is often accompanied by enlargement of the frontal and temporal horns of the lateral ventricles as highlighted by the arrows. Additionally, loss of pigmented neurons in the locus coeruleus is commonly observed in the pontine tegmentum as shown with the open circle. None of these features is exclusive to Alzheimers disease
The definitive diagnosis of AD requires microscopic examination of multiple brain regions employing staining methods that can detect Alzheimer type neuropathologic change , with diagnosis based upon the morphology and density of lesions and their topographic distribution. Several of the brain regions that are vulnerable to Alzheimer type pathologic change are also vulnerable to other disease processes, such as -synucleinopathy and TDP-43 proteinopathy. Mixed pathology is common. Indeed in the Mayo Clinic Brain Bank from 2007 to 2016 , the majority of AD cases had coexisting non-Alzheimer pathologies, and comorbidities increased in frequency with age. Furthermore, when the original clinical diagnoses were examined for cases with pure AD pathology, it is clear that a number of clinical syndromes can masquerade as Alzheimers disease.
Medical History Of Alzheimers Disease
The medical history consists of written and/or verbal questions about past illnesses, current illnesses, any medication or drug use, alcohol consumption, and family medical history. Even things that might not seem relevant can give the physician important clues as to what might be causing the symptoms. It is often helpful for the patient to bring along a close family member or caregiver. Not only does this provide added support for the patient, but the doctor can then ask them questions about symptoms, behavior, and medical history which is especially important if the person cannot remember their medical history or is an unreliable reporter.
You May Like: How To Get Tested For Alzheimer’s Gene
What Research Is Garvan Doing In This Area
The Garvan Institute is taking a range of approaches to investigate Alzheimers disease.;Our scientists are researching the mechanisms at the synapses that are important in memory formation and trying to;understand if these mechanisms are somehow involved in contributing to neuronal death;in Alzheimers disease.; In particular, we focus on signalling pathways regulating neuroplasticity, or the ability of the brain to change or re-wire itself.; This process is uniquely advanced in humans and defects can lead to neurodegeneraive disorders.; We have mapped new pathways controlling neuroplasticity and are currently determining if they are dysregulated in the brains of Alzheimers patients.; The goal of this work is to identify novel therapeutic targets or biomarkers that can be used for early and specific detection of Alzheimers Disease.
This content is provided for informational purposes only. It is not a substitute for professional medical advice, diagnosis or treatment. If you have any concerns or questions about your health, please consult a suitably qualified healthcare professional.
- Affects up to 70% of all people with dementia
- Occurs in 3 out of 10 people over the age of 85
- Women are at a higher risk of developing Alzheimers
Your support makes it possible for the Garvan scientists to continue their great work. You can help by making a donation today.
Referral To A Specialist
If a GP is unsure about whether you have Alzheimer’s disease, they may refer you to a specialist, such as:
- a psychiatrist
- an elderly care physician
- a neurologist
The specialist may be based in a memory clinic alongside other professionals who are experts in diagnosing, caring for and advising people with dementia and their families.
There’s no simple and reliable test for diagnosing Alzheimer’s disease, but the staff at the memory clinic will listen to the concerns of both you and your family about your memory or thinking.
They’ll assess your memory and other areas of mental ability and, if necessary, arrange more tests to rule out other conditions.
Don’t Miss: How To Treat Agitation In Dementia Patients
Can A Smell Test Sniff Out Alzheimer’s Disease
The sense of smell is one of the first things to change as Alzheimers disease takes root, even before other symptoms appear. Thats raised the idea that a scratch-and-sniff test that rates an individuals ability to identify odors could potentially detect the disease earlyallowing patients to begin treatment before symptoms become harder to treat. Columbia neurologist William Kreisl, MD, has been studying a smell identification test and explains what it canand cantsay about Alzheimers.
Whats the connection between smell and Alzheimers disease?
The olfactory bulbwhich sends smell information from the nose to the brainis one of the first areas of the brain to sustain damage in Alzheimers disease. Brain areas that receive information from the olfactory bulb, such as the entorhinal cortex, are also affected early in the disease. As a result, impaired ability to recognize odors often occurs in people with early-stage Alzheimers before memory symptoms are noticed.
Previous studies have suggested that individuals who scored poorly on the smell test were more likely to have had neurodegenerative changes in the brain caused by Alzheimers, such as a buildup of beta amyloid deposits, or plaques.
Can the smell identification test tell me right now if Im going to get Alzheimers?
We think this is a good first study in looking at the ability of smell test to predict memory decline, but we would need to replicate our findings in a larger study.
New Thinking About Alzheimer’s Diagnosis
New technology and biomarkers have contributed to the detection of Alzheimer’s disease, but clinicians are skeptical about the value of a diagnosis without the ability to treat the condition.
Clinical presentation used to be the only way to diagnose Alzheimer’s disease. Patients would report symptoms characteristic of dementia, including memory loss or difficulty with attention and concentration, and physicians would use the process of elimination to arrive at a presumptive diagnosis.
The advent of neuroimaging technologies that illuminate amyloid plaques in the brain has begun to change that, however, and in 2018, the National Institute on Aging and Alzheimer’s Association published an updated research framework that proposed to define Alzheimer’s as a biological disease determined by the presence of specific biomarkers in the brain.
It’s a big departure from the way we used to diagnose Alzheimer’s based on clinical presentation and ruling out other possibilities, said Ronald Petersen, MD, PhD, director of the Mayo Clinic’s Alzheimer’s Disease Research Center and Study of Aging in Rochester, Minn. We now know that Alzheimer’s is defined by the presence of amyloid plaques and neurofibrillary tangles in the brain, regardless of the clinical presentation.
Symptoms And Medical History
Your doctor will ask you what symptoms you are experiencing, how long you have had them, how severe they are, and whether they interfere with your ability to go about your daily routine.
Your doctor will also ask for a detailed medical history that may include information about:
- Medications you are currently taking or have previously taken
- Previous illnesses, surgeries, and procedures
- Family medical history
- Diet and lifestyle
This can help your doctor evaluate risk factors that might predispose you to Alzheimers. It can also help identify medications or illnesses that can cause symptoms similar to those of Alzheimers.
What Are The Symptoms Of Alzheimers
Alzheimers disease begins slowly, with the first symptoms usually being mild forgetfulness;and visual-spatial confusion. However, as the disease progresses, these symptoms may;begin to interfere with daily activities, such as navigating through familiar areas or recognising people or objects.
In the middle stages of the disease, people with Alzheimers may have difficulty doing basic;tasks like brushing their teeth, speaking, reading and writing. Patients may become anxious,;agitated or aggressive and will eventually need total care. In the last stages of the disease,;deterioration of musculature and mobility occurs. Patients become bedridden and death;ensues, often from pneumonia.
How The Test Works
The test is performed with a lumbar puncture, a 30- to 40-minute procedure, performed with a local anesthetic, to collect the fluid. Fewer;than 5 percent of patients experience a headache after this procedure.
This test is much easier to administer and is much safer than many people think, says Mayeux. It also costs around $1,000 versus $3,500 for amyloid PET scan.